<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047762/" ref="ordinalpos=814&amp;ncbi_uid=6206667&amp;link_uid=PMC4047762" image-link="/pmc/articles/PMC4047762/figure/F6/" class="imagepopup">Figure 6. Working Model for ALK1 <span class="highlight" style="background-color:">Signaling</span> in ECs.  From: ALK1 <span class="highlight" style="background-color:">Signaling</span> Inhibits Angiogenesis by Cooperating with the Notch <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">The data suggest that ALK1 signaling, triggered upon BMP9 binding, activates SMAD1,5,8 signaling, which induces expression of HES1, HEY1, and HEY2 together with Notch signaling. ALK1 also induces expression of UNC5B and VEGFR1, therefore reducing VEGF response and tip cell specification. This modulation of gene expression by Alk1 contributes to the stability and quiescence of the endothelium.</div></div>